57. Update from the HIV Prevention Trials Network (HPTN)
Session: Symposium: Research Highlights from the NIH AIDS Networks and Observational Cohorts
Thursday, October 20, 2011: 1:30 PM
Room: 210ABC
A dozen clinical trials are in progress within the HPTN designed to further technologies and strategies to reduce HIV transmission among adults in the Americas, Africa, and Asia. Dr. Vermund will present highlights of results from trials that had major public findings in 2011, and discuss work in progress of particular interest to IDSA members. These will include combination prevention approaches, ART for prevention, pre-exposure prophylaxis, and behavioral and structural interventions.  American health disparities will be discussed in the context of recently completed US trials.

Sten Vermund, MD, PhD, FIDSA, Vanderbilt University School of Medicine, Nashville, TN

Sten H. Vermund, MD, PhD is Amos Christie Chair in Global Health, Professor of Pediatrics, and Director of the university-wide Vanderbilt Institute for Global Health. He obtained a BA in Human Biology from Stanford, did his MD at the Albert Einstein College of Medicine, and trained in public health (London School of Hygiene and Tropical Medicine) and epidemiology (Columbia U.) after completing his Pediatrics training at Babies Hospital (Columbia-Presbyterian Medical Center). From stints on the Columbia and Einstein faculties in the 1980s, Sten went to the NIAID, NIH to head the Vaccine Trials and Epidemiology Branch at the Division of AIDS in 1988. In 1994, he became Chairman, Department of Epidemiology, and Director, Division of Geographic Medicine at UAB. Sten has been at Vanderbilt since 2005. He has founded two organizations to spearhead HIV prevention, care, and treatment in Africa, the Centre for Infectious Disease Research in Zambia and Friends in Global Health in Mozambique and Nigeria. Since 2005, Sten has led the HIV Prevention Trials Network for the NIH, and holds research and training grants in HIV/AIDS, African medical education, and US global research. He received the Superior Service Award from the US Public Health Service in 1994 and the Albert Einstein College of Medicine lifetime alumni achievement award in 2010.

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.